Table 1

Assessment instruments proposed for the current study

Instrument

Initial

15-wk

12-, 18-, 24-, 30- 36-months

Tobacco Use

Opiate Treatment Index (OTI, quantity/frequency) [14]

√

√

√

Point Prevalence and Continuous Abstinence

√

√

√

Readiness to Quit Smoking [15]

√

-

-

Fagerstrom Test for Nicotine Dependence [16]

√

√

√

Expired Carbon Monoxide

√

√

√

Minnesota Nicotine Withdrawal Scale (MNWS-R)[17]

√

√

√

Physical Activity

Readiness to change physical activity [18]

√

-

-

Physical activity screen (past week)

√

√

√

Average minutes walking per week

√

√

√

International Physical Activity Questionnaire [19]

√

√

√

Dietary Habits

Readiness to change eating habits

√

-

-

24-hour recall of eating patterns

√

√

√

Other CVD Risk Factors

OTI- alcohol and cannabis

√

√

√

Beck Depression Inventory - II [20]

√

√

√

Brief Symptom Inventory [21]

√

√

√

Body mass index (height, weight)

√

√

√

Waist-hip ratio (cms)

√

√

√

Auscultatory Blood pressure

√

√

√

Fingerprick Blood Tests (glucose, cholesterol, lipids)

√

√

√

Treatment and Service Utilisation [22]

√

√

√

Diagnosis of psychosis and Symptom Measure

Brief Psychiatric Rating Scale [23]

√

√

√

Mini International Neuropsychiatric Interview [22]

√

-

-

Functioning

Global Assessment of Functioning [24]

√

√

√

Medical Outcome Survey SF-36 [25]

√

√

√

Quality of Life Scale [26]

√

√

√

Impact of Weight on Quality of Life Questionnaire [27]

√

√

√

Therapeutic Alliance & Intervention Satisfaction [28]

-

√

-

Baker et al. BMC Public Health 2011 11:10   doi:10.1186/1471-2458-11-10